More than 300 hospital consultants, general practitioners, nurses, academics and other healthcare professionals received payments or expenses last year from Novo Nordisk, the company behind new obesity drug Ozempic

7 comments

1. Figures disclosed by the company show in total it paid Irish healthcare staff €446,000 last year in fees for sponsored talks, consultancy work or to cover travel expenses, as its new drugs gained popularity.

   The company paid a further €250,000 to universities, hospitals or other organisations in grants or donations.

2. Apparently the company that makes it is worth more than the Danish economy.

3. Novo Nordisk was suspended from the UK’s pharma industry body earlier this year, as the nature of its sponsorship of a weight management course for health professionals breached a code of practice.

   The Ipha, the Irish industry body, said it had received no complaints of breaches of its code of practice about Novo Nordisk in the past two years.

4. Yeah but they also are ignoring that a lot of people have serious gastro side effects from this drug and it’s being swept under the carpet cause of the financials.

5. Novo Nordisk made a lot of money with human growth hormone which they harvested from the organs of dead babies that Irish doctors provided for them for surprisingly petty bribes. Parents were never consulted when their baby’s pancreas were removed and replaced with a bageen of sand to make up the weight.

6. Who do you think pays for clinical trials, and who do you think runs them ??

7. Aren’t people fat enough already? Surely an _anti_ -obesity drug would make more sense.